| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Immunologic Deficiency Syndromes | 6 | 2021 | 205 | 0.750 |
Why?
|
| Blood Group Incompatibility | 2 | 2018 | 27 | 0.720 |
Why?
|
| ABO Blood-Group System | 2 | 2018 | 66 | 0.710 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 10 | 2023 | 1097 | 0.710 |
Why?
|
| Nonsense Mediated mRNA Decay | 1 | 2018 | 29 | 0.590 |
Why?
|
| Severe Combined Immunodeficiency | 3 | 2016 | 106 | 0.570 |
Why?
|
| Molecular Chaperones | 1 | 2018 | 168 | 0.550 |
Why?
|
| Mutation | 8 | 2024 | 5904 | 0.540 |
Why?
|
| Rare Diseases | 3 | 2017 | 191 | 0.500 |
Why?
|
| Liver Transplantation | 3 | 2019 | 1042 | 0.480 |
Why?
|
| Granulomatous Disease, Chronic | 3 | 2020 | 66 | 0.480 |
Why?
|
| Genetic Predisposition to Disease | 4 | 2018 | 3176 | 0.430 |
Why?
|
| Autoimmune Diseases | 3 | 2018 | 252 | 0.300 |
Why?
|
| Developmental Disabilities | 3 | 2023 | 715 | 0.300 |
Why?
|
| Mitochondrial Proton-Translocating ATPases | 1 | 2018 | 20 | 0.290 |
Why?
|
| Heterozygote | 2 | 2022 | 673 | 0.290 |
Why?
|
| Lymphohistiocytosis, Hemophagocytic | 2 | 2020 | 146 | 0.280 |
Why?
|
| Protein Subunits | 1 | 2018 | 165 | 0.280 |
Why?
|
| Infant | 17 | 2023 | 12601 | 0.270 |
Why?
|
| Molecular Sequence Annotation | 1 | 2017 | 148 | 0.260 |
Why?
|
| Child, Preschool | 16 | 2024 | 14145 | 0.260 |
Why?
|
| Genome, Human | 2 | 2018 | 1292 | 0.260 |
Why?
|
| Metabolic Diseases | 1 | 2018 | 130 | 0.260 |
Why?
|
| Child | 22 | 2023 | 24606 | 0.250 |
Why?
|
| Coatomer Protein | 2 | 2016 | 30 | 0.250 |
Why?
|
| Syndrome | 4 | 2023 | 1121 | 0.240 |
Why?
|
| Exome | 3 | 2022 | 1034 | 0.240 |
Why?
|
| Virus Diseases | 2 | 2019 | 281 | 0.240 |
Why?
|
| Alleles | 2 | 2018 | 1618 | 0.230 |
Why?
|
| Humans | 43 | 2024 | 125358 | 0.220 |
Why?
|
| Infant, Newborn | 9 | 2022 | 8273 | 0.220 |
Why?
|
| Ikaros Transcription Factor | 1 | 2023 | 28 | 0.210 |
Why?
|
| Cord Blood Stem Cell Transplantation | 1 | 2023 | 46 | 0.200 |
Why?
|
| Male | 22 | 2024 | 61561 | 0.200 |
Why?
|
| Software | 1 | 2017 | 687 | 0.200 |
Why?
|
| Replication Protein A | 1 | 2022 | 11 | 0.190 |
Why?
|
| Mycobacterium bovis | 1 | 2022 | 30 | 0.190 |
Why?
|
| Genetic Variation | 2 | 2017 | 1505 | 0.190 |
Why?
|
| Hearing Loss | 1 | 2023 | 136 | 0.190 |
Why?
|
| Telomere Shortening | 1 | 2022 | 33 | 0.190 |
Why?
|
| Interferon Type I | 2 | 2021 | 108 | 0.190 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2024 | 561 | 0.190 |
Why?
|
| Craniofacial Abnormalities | 1 | 2023 | 239 | 0.180 |
Why?
|
| Hereditary Autoinflammatory Diseases | 1 | 2021 | 10 | 0.180 |
Why?
|
| Gain of Function Mutation | 1 | 2022 | 107 | 0.180 |
Why?
|
| Neurodevelopmental Disorders | 1 | 2016 | 501 | 0.180 |
Why?
|
| Afibrinogenemia | 1 | 2021 | 10 | 0.180 |
Why?
|
| Agammaglobulinemia | 1 | 2021 | 41 | 0.180 |
Why?
|
| Myelodysplastic Syndromes | 1 | 2022 | 125 | 0.180 |
Why?
|
| I-kappa B Kinase | 2 | 2022 | 61 | 0.170 |
Why?
|
| Chromosomes, Human, Pair 6 | 1 | 2021 | 143 | 0.170 |
Why?
|
| Fibrinogen | 1 | 2021 | 156 | 0.170 |
Why?
|
| Telomere | 1 | 2022 | 220 | 0.170 |
Why?
|
| Endoplasmic Reticulum Stress | 2 | 2018 | 120 | 0.170 |
Why?
|
| Immunotherapy, Adoptive | 2 | 2017 | 832 | 0.170 |
Why?
|
| Female | 21 | 2022 | 66815 | 0.170 |
Why?
|
| Anaphylaxis | 1 | 2021 | 81 | 0.160 |
Why?
|
| Base Sequence | 2 | 2018 | 3111 | 0.160 |
Why?
|
| Hyper-IgM Immunodeficiency Syndrome | 1 | 2019 | 1 | 0.160 |
Why?
|
| Vaccines, Attenuated | 1 | 2019 | 175 | 0.160 |
Why?
|
| Graft Rejection | 2 | 2023 | 588 | 0.160 |
Why?
|
| Microcephaly | 1 | 2022 | 331 | 0.160 |
Why?
|
| Intellectual Disability | 2 | 2022 | 1054 | 0.150 |
Why?
|
| Hypersensitivity | 1 | 2021 | 185 | 0.150 |
Why?
|
| Sequence Analysis, DNA | 3 | 2018 | 1763 | 0.150 |
Why?
|
| Cholangitis, Sclerosing | 1 | 2019 | 59 | 0.150 |
Why?
|
| Phenotype | 4 | 2018 | 4270 | 0.150 |
Why?
|
| Unfolded Protein Response | 1 | 2018 | 62 | 0.150 |
Why?
|
| Arthritis | 2 | 2016 | 81 | 0.140 |
Why?
|
| Alemtuzumab | 1 | 2018 | 86 | 0.140 |
Why?
|
| Mutant Proteins | 1 | 2018 | 114 | 0.140 |
Why?
|
| Wiskott-Aldrich Syndrome | 1 | 2017 | 23 | 0.140 |
Why?
|
| Immunosuppressive Agents | 2 | 2019 | 645 | 0.140 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2021 | 559 | 0.140 |
Why?
|
| Chromatin | 1 | 2021 | 579 | 0.140 |
Why?
|
| Frameshift Mutation | 1 | 2018 | 181 | 0.140 |
Why?
|
| Immunophenotyping | 1 | 2018 | 327 | 0.140 |
Why?
|
| Postoperative Care | 1 | 2019 | 301 | 0.140 |
Why?
|
| Paramyxoviridae Infections | 1 | 2017 | 46 | 0.140 |
Why?
|
| Metapneumovirus | 1 | 2017 | 50 | 0.140 |
Why?
|
| Clinical Protocols | 1 | 2018 | 240 | 0.140 |
Why?
|
| Adolescent | 13 | 2022 | 19423 | 0.140 |
Why?
|
| Hernias, Diaphragmatic, Congenital | 1 | 2022 | 399 | 0.140 |
Why?
|
| Organ Transplantation | 1 | 2019 | 168 | 0.140 |
Why?
|
| Trans-Activators | 1 | 2021 | 801 | 0.140 |
Why?
|
| Antibodies, Monoclonal, Humanized | 1 | 2021 | 509 | 0.140 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2018 | 262 | 0.130 |
Why?
|
| Postoperative Complications | 2 | 2019 | 3056 | 0.130 |
Why?
|
| Cell Line | 2 | 2021 | 2756 | 0.130 |
Why?
|
| Transcription Factors | 1 | 2016 | 2603 | 0.130 |
Why?
|
| Autism Spectrum Disorder | 1 | 2022 | 392 | 0.130 |
Why?
|
| Genetic Association Studies | 2 | 2017 | 779 | 0.130 |
Why?
|
| Heart Transplantation | 1 | 2023 | 859 | 0.130 |
Why?
|
| Young Adult | 9 | 2023 | 9058 | 0.130 |
Why?
|
| Molecular Diagnostic Techniques | 1 | 2017 | 152 | 0.130 |
Why?
|
| Pneumatosis Cystoides Intestinalis | 1 | 2016 | 9 | 0.130 |
Why?
|
| Transplantation Conditioning | 1 | 2017 | 279 | 0.130 |
Why?
|
| Tuberculosis | 1 | 2022 | 527 | 0.130 |
Why?
|
| Common Variable Immunodeficiency | 1 | 2016 | 28 | 0.120 |
Why?
|
| Homeodomain Proteins | 1 | 2019 | 556 | 0.120 |
Why?
|
| High-Throughput Nucleotide Sequencing | 2 | 2018 | 887 | 0.120 |
Why?
|
| Exons | 1 | 2018 | 802 | 0.120 |
Why?
|
| Immunization, Passive | 1 | 2016 | 120 | 0.120 |
Why?
|
| Autoimmunity | 2 | 2019 | 172 | 0.120 |
Why?
|
| Enteritis | 1 | 2016 | 54 | 0.120 |
Why?
|
| Dendritic Cells | 2 | 2021 | 414 | 0.120 |
Why?
|
| Family | 1 | 2018 | 561 | 0.120 |
Why?
|
| Golgi Apparatus | 1 | 2015 | 93 | 0.120 |
Why?
|
| Drug Therapy, Combination | 1 | 2018 | 1172 | 0.120 |
Why?
|
| Follow-Up Studies | 3 | 2018 | 5171 | 0.120 |
Why?
|
| T-Lymphocytes | 3 | 2021 | 1720 | 0.110 |
Why?
|
| Inflammation | 2 | 2019 | 1445 | 0.110 |
Why?
|
| RNA, Messenger | 2 | 2018 | 2813 | 0.110 |
Why?
|
| End Stage Liver Disease | 1 | 2016 | 182 | 0.110 |
Why?
|
| Lung Diseases, Interstitial | 1 | 2015 | 149 | 0.100 |
Why?
|
| Treatment Outcome | 5 | 2024 | 12287 | 0.100 |
Why?
|
| Skin Diseases | 1 | 2014 | 129 | 0.100 |
Why?
|
| Caliciviridae Infections | 1 | 2016 | 328 | 0.100 |
Why?
|
| Cytokines | 2 | 2021 | 1291 | 0.100 |
Why?
|
| Chemokines | 1 | 2012 | 134 | 0.100 |
Why?
|
| Killer Cells, Natural | 1 | 2014 | 327 | 0.100 |
Why?
|
| Genetic Testing | 1 | 2018 | 1016 | 0.090 |
Why?
|
| Immunoglobulins | 2 | 2024 | 173 | 0.090 |
Why?
|
| DiGeorge Syndrome | 1 | 2011 | 80 | 0.090 |
Why?
|
| STAT3 Transcription Factor | 1 | 2012 | 218 | 0.090 |
Why?
|
| Papillomavirus Infections | 1 | 2014 | 296 | 0.090 |
Why?
|
| Adult | 9 | 2023 | 29540 | 0.090 |
Why?
|
| Delayed Diagnosis | 1 | 2011 | 126 | 0.080 |
Why?
|
| Retrospective Studies | 5 | 2023 | 16363 | 0.080 |
Why?
|
| Glioblastoma | 1 | 2012 | 346 | 0.080 |
Why?
|
| Amino Acid Sequence | 2 | 2018 | 2718 | 0.070 |
Why?
|
| Enterobacteriaceae | 1 | 2008 | 35 | 0.070 |
Why?
|
| Enterobacteriaceae Infections | 1 | 2008 | 54 | 0.070 |
Why?
|
| Genitalia | 1 | 2016 | 36 | 0.070 |
Why?
|
| Biopsy | 2 | 2023 | 1244 | 0.070 |
Why?
|
| Genotype | 2 | 2017 | 2570 | 0.070 |
Why?
|
| Loss of Function Mutation | 1 | 2018 | 150 | 0.070 |
Why?
|
| Genotyping Techniques | 1 | 2017 | 105 | 0.070 |
Why?
|
| Speech Disorders | 1 | 2016 | 43 | 0.070 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 2017 | 133 | 0.070 |
Why?
|
| Zinc Fingers | 1 | 2016 | 119 | 0.060 |
Why?
|
| Whole Genome Sequencing | 2 | 2018 | 283 | 0.060 |
Why?
|
| HEK293 Cells | 2 | 2021 | 739 | 0.060 |
Why?
|
| Muscle Hypotonia | 1 | 2016 | 187 | 0.060 |
Why?
|
| Education, Professional | 1 | 2005 | 10 | 0.060 |
Why?
|
| Community Networks | 1 | 2005 | 33 | 0.060 |
Why?
|
| Central Nervous System | 1 | 2016 | 257 | 0.060 |
Why?
|
| Ataxia | 1 | 2016 | 170 | 0.060 |
Why?
|
| Cross Infection | 1 | 2008 | 325 | 0.060 |
Why?
|
| Information Dissemination | 1 | 2017 | 186 | 0.060 |
Why?
|
| Databases, Genetic | 1 | 2017 | 475 | 0.060 |
Why?
|
| Cell Differentiation | 2 | 2022 | 1909 | 0.050 |
Why?
|
| Qualitative Research | 1 | 2017 | 540 | 0.050 |
Why?
|
| Lung Diseases | 2 | 2019 | 385 | 0.050 |
Why?
|
| Metabolomics | 1 | 2017 | 422 | 0.050 |
Why?
|
| Busulfan | 1 | 2023 | 41 | 0.050 |
Why?
|
| Erythrocyte Count | 1 | 2003 | 21 | 0.050 |
Why?
|
| Brain Neoplasms | 1 | 2012 | 1315 | 0.050 |
Why?
|
| Mitochondria | 1 | 2018 | 680 | 0.050 |
Why?
|
| Spinal Puncture | 1 | 2003 | 53 | 0.050 |
Why?
|
| Transposases | 1 | 2022 | 44 | 0.050 |
Why?
|
| Survival Rate | 2 | 2017 | 2050 | 0.050 |
Why?
|
| BCG Vaccine | 1 | 2022 | 108 | 0.050 |
Why?
|
| Tumor Necrosis Factor alpha-Induced Protein 3 | 1 | 2021 | 10 | 0.050 |
Why?
|
| Lymphopoiesis | 1 | 2021 | 10 | 0.050 |
Why?
|
| Precursor Cells, B-Lymphoid | 1 | 2021 | 17 | 0.050 |
Why?
|
| Emergency Medical Services | 1 | 2005 | 397 | 0.040 |
Why?
|
| Cyclophosphamide | 1 | 2023 | 412 | 0.040 |
Why?
|
| Abnormalities, Multiple | 1 | 2016 | 960 | 0.040 |
Why?
|
| Health Personnel | 1 | 2005 | 510 | 0.040 |
Why?
|
| Haploinsufficiency | 1 | 2021 | 258 | 0.040 |
Why?
|
| Spinal Cord Injuries | 1 | 2003 | 313 | 0.040 |
Why?
|
| Genomics | 2 | 2018 | 1520 | 0.040 |
Why?
|
| Hematopoiesis | 1 | 2021 | 215 | 0.040 |
Why?
|
| Cardiac Catheterization | 1 | 2023 | 633 | 0.040 |
Why?
|
| Middle Aged | 4 | 2022 | 26765 | 0.040 |
Why?
|
| Chimerism | 1 | 2018 | 28 | 0.040 |
Why?
|
| B-Lymphocytes | 1 | 2021 | 532 | 0.040 |
Why?
|
| Guillain-Barre Syndrome | 1 | 2018 | 27 | 0.040 |
Why?
|
| Pancytopenia | 1 | 2018 | 41 | 0.040 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2020 | 319 | 0.040 |
Why?
|
| Unrelated Donors | 1 | 2018 | 67 | 0.040 |
Why?
|
| Fatal Outcome | 1 | 2019 | 357 | 0.040 |
Why?
|
| Gene Deletion | 1 | 2021 | 793 | 0.040 |
Why?
|
| Granzymes | 1 | 2017 | 37 | 0.040 |
Why?
|
| Immunodominant Epitopes | 1 | 2017 | 50 | 0.030 |
Why?
|
| Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2017 | 69 | 0.030 |
Why?
|
| Multifactorial Inheritance | 1 | 2018 | 139 | 0.030 |
Why?
|
| Allografts | 1 | 2017 | 176 | 0.030 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2021 | 538 | 0.030 |
Why?
|
| Combined Modality Therapy | 1 | 2020 | 1240 | 0.030 |
Why?
|
| Immunity, Cellular | 1 | 2017 | 206 | 0.030 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2021 | 1006 | 0.030 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2017 | 325 | 0.030 |
Why?
|
| Sepsis | 1 | 2020 | 484 | 0.030 |
Why?
|
| Stem Cells | 1 | 2021 | 709 | 0.030 |
Why?
|
| Pathology, Molecular | 1 | 2016 | 60 | 0.030 |
Why?
|
| Cohort Studies | 2 | 2018 | 4828 | 0.030 |
Why?
|
| Disease-Free Survival | 1 | 2017 | 880 | 0.030 |
Why?
|
| Immunocompromised Host | 1 | 2017 | 294 | 0.030 |
Why?
|
| Duodenum | 1 | 2016 | 101 | 0.030 |
Why?
|
| Lod Score | 1 | 2015 | 120 | 0.030 |
Why?
|
| Interferon-gamma | 1 | 2017 | 505 | 0.030 |
Why?
|
| DNA-Binding Proteins | 1 | 2023 | 2061 | 0.030 |
Why?
|
| Incidence | 2 | 2018 | 3133 | 0.030 |
Why?
|
| Feasibility Studies | 1 | 2017 | 762 | 0.030 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2017 | 682 | 0.030 |
Why?
|
| Endoplasmic Reticulum | 1 | 2015 | 217 | 0.030 |
Why?
|
| Viral Load | 1 | 2016 | 388 | 0.030 |
Why?
|
| Protein Transport | 1 | 2015 | 369 | 0.030 |
Why?
|
| Genetic Diseases, Inborn | 1 | 2017 | 442 | 0.030 |
Why?
|
| Prevalence | 2 | 2011 | 2467 | 0.030 |
Why?
|
| Aminosalicylic Acids | 1 | 2012 | 1 | 0.030 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2016 | 1065 | 0.030 |
Why?
|
| Benzenesulfonates | 1 | 2012 | 12 | 0.030 |
Why?
|
| Electrophoretic Mobility Shift Assay | 1 | 2012 | 49 | 0.030 |
Why?
|
| Prospective Studies | 1 | 2023 | 6142 | 0.020 |
Why?
|
| Proportional Hazards Models | 1 | 2016 | 1362 | 0.020 |
Why?
|
| Graft vs Host Disease | 1 | 2016 | 503 | 0.020 |
Why?
|
| Kidney Diseases | 1 | 2016 | 485 | 0.020 |
Why?
|
| United States | 1 | 2017 | 10908 | 0.020 |
Why?
|
| Prognosis | 1 | 2021 | 4686 | 0.020 |
Why?
|
| Pedigree | 1 | 2015 | 1610 | 0.020 |
Why?
|
| DNA Copy Number Variations | 1 | 2016 | 963 | 0.020 |
Why?
|
| Lipopolysaccharides | 1 | 2012 | 297 | 0.020 |
Why?
|
| Tumor Cells, Cultured | 1 | 2012 | 1077 | 0.020 |
Why?
|
| Genome-Wide Association Study | 1 | 2018 | 1694 | 0.020 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2012 | 508 | 0.020 |
Why?
|
| RNA, Small Interfering | 1 | 2012 | 670 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2012 | 1111 | 0.020 |
Why?
|
| Pediatrics | 1 | 2019 | 1158 | 0.020 |
Why?
|
| Molecular Sequence Data | 1 | 2015 | 3900 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2012 | 1294 | 0.020 |
Why?
|
| Age Factors | 1 | 2016 | 2818 | 0.020 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2017 | 2656 | 0.020 |
Why?
|
| Sentinel Surveillance | 1 | 2008 | 19 | 0.020 |
Why?
|
| District of Columbia | 1 | 2008 | 17 | 0.020 |
Why?
|
| Intensive Care, Neonatal | 1 | 2008 | 54 | 0.020 |
Why?
|
| Molecular Epidemiology | 1 | 2008 | 155 | 0.020 |
Why?
|
| Anti-Bacterial Agents | 1 | 2019 | 2430 | 0.020 |
Why?
|
| Drug Resistance, Multiple, Bacterial | 1 | 2008 | 133 | 0.020 |
Why?
|
| Infection Control | 1 | 2008 | 156 | 0.020 |
Why?
|
| Commonwealth of Independent States | 1 | 2005 | 1 | 0.020 |
Why?
|
| International Agencies | 1 | 2005 | 30 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 1 | 2008 | 1592 | 0.010 |
Why?
|
| Emergency Medicine | 1 | 2005 | 150 | 0.010 |
Why?
|
| Schools | 1 | 2005 | 218 | 0.010 |
Why?
|
| Risk Factors | 1 | 2017 | 10296 | 0.010 |
Why?
|
| Hospitals, Pediatric | 1 | 2008 | 766 | 0.010 |
Why?
|
| Cerebrospinal Fluid | 1 | 2003 | 94 | 0.010 |
Why?
|
| Subarachnoid Hemorrhage | 1 | 2003 | 70 | 0.010 |
Why?
|
| Faculty, Medical | 1 | 2005 | 262 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2012 | 4595 | 0.010 |
Why?
|
| Curriculum | 1 | 2005 | 727 | 0.010 |
Why?
|
| Aged | 1 | 2016 | 19727 | 0.010 |
Why?
|
| Emergency Service, Hospital | 1 | 2003 | 1068 | 0.010 |
Why?
|